Welcome to the CropLife International database of published papers and reviews demonstrating the benefits and safety implications associated with the use of agricultural biotechnology products.
In 2018, 26 countries grew 191.7 million hectares of biotech crops – an increase of 1.9 million hectares from 2017. The average biotech crop adoption rate in the top five biotech crop-growing countries increased in 2018 to reach close to saturation, with USA at 93.3% (average for soybeans, maize, and canola adoption), Brazil (93%), Argentina (~100%), Canada (92.5%), and India (95%). Future expansion of biotech crop areas in these countries would be through immediate approval and commercialization of new biotech crops and traits to target problems related to climate change and the emergence of new pests and diseases.
Biotech crops however have already expanded beyond the big four (maize, soybeans, cotton, and canola) to give more choices for many of the world’s consumers and food producers. These biotech crops include alfalfa, sugar beets, papaya, squash, eggplant, potatoes, and apples, all of which are already in the market.
While studies recording, demonstrating and quantifying the benefits of biotechnology are available, they can be difficult to find. The purpose of this database is to enable you to quickly and easily locate and access credible scientific information about the demonstrated benefits of agricultural biotechnology products and the safety implications associated with their use.
All the papers have either been published in peer-reviewed journals or have been prepared by organisations that have summarised peer-reviewed studies.
Papers are organised primarily by the different categories of impact of biotechnology, with links on the left column to each impact category. Clicking on the link provides a summary and description of the impact and a list of papers in the database that relate to the relevant impact category.
The database search allows you to further specify your filters to find the right paper of interest. This option is interactive with the search results updating as soon as a parameter is changed.
The list of studies is being continuously added to and updated, and your suggestions for the inclusion of additional studies are welcome via this form.
Chronic Toxicity of Genetically Modified Maize with Cry1Ab-ma Gene and Its Effect on Serum Metabolites in Rats
(2023) Wang Y, Hu Y-C, Lu J-X, Mao D-Q, Wang R, Liu X-B, Chen J, Wu W-X, Li M
Survivorship and food consumption of immatures and adults of Apis mellifera and Scaptotrigona bipunctata exposed to genetically modified eucalyptus pollen
(2023) Dos Santos CA, Ramos JD, de Carvalho FG, et al.
A 90-day rodent feeding study with grain for genetically modified maize L4 conferring insect resistance and glyphosate tolerance
(2023) Zhang J, Liu Y, Li S, Zhou Q, Zhang L, Zhang S, Zhou X, Wu C, Qian ZY
Assessment of genetically modified maize DP4114 × MON 810 × MIR604 × NK603 and subcombinations, for food and feed uses, under Regulation (EC) No 1829/2003 (application EFSA-GMO-NL-2018-150)
(2022) EFSA Panel on GMOs
Genetically modified DP915635 maize is agronomically and compositionally comparable to non-genetically modified maize
(2023) Anderson JA, Mickelson J, Fast Bj, Smith N, Pauli RC, Walker C